Industry Happenings: DCAT Week ’17 at the Pulse of Pharma Development and Manufacturing


Pharmaceutical companies and contract service providers and suppliers supporting pharmaceutical and biopharmaceutical production will gather in New York City on March 20–23 for DCAT Week, a global industry event organized by the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is a global business development association, composed of more than 400 corporate members, which include innovator and generic drug companies and suppliers of ingredients, development and manufacturing services, and related technologies. DCAT Week brings together member representatives involved in the business of pharmaceutical development and manufacturing for high-level strategic meetings, education programs, and networking opportunities.
DCAT Week ’17 will feature six education programs; some key highlights from several programs are noted below.

Pharma Industry Outlook: Market Overview and Executive Insights will feature a global pharmaceutical industry market overview and an Executive Forum with John LaMattina, PhD, Former Senior Vice President, Pfizer Inc. and Former President, Pfizer Global Research and Development, on the macro issues impacting drug development and commercialization.

Pharma Outsourcing: The Numbers, Trends, and Partnership Strategies examines the drivers for contract development and manufacturing services for drug substances and drug products as well as insights on new partnership models in pharmaceutical outsourcing, including a view of pharma manufacturing in China. 

Emerging Pharma: Market Overview, Innovation in Project Management and CMC Readiness is a new DCAT Week program exploring the specialized requirements of small pharmaceutical companies in the sponsor company–supplier relationship, including project management, and the role that CMC (chemistry, manufacturing and controls) readiness plays in investor valuations and partnering decisions by larger pharma companies. 

The Future of Sourcing and Procurement program will feature insights from pharmaceutical companies on several topics: the future of sourcing and procurement (Bristol-Myers Squibb), best practices for materials management for complex supply chains with a focus on antibody drug conjugates (Pfizer), and strategies for supplier-led innovation (Janssen Pharmaceuticals).

Further information on these programs and the other DCAT Week ’17 education programs may be found at